8-K Reports
AIM ImmunoTech Inc.
CIK

946644

Accepted

Jan 12, 2026, 10:19 PM

Accession

0001493152-26-001898

7.01 Regulation FD Disclosure
9.01 Financial Statements and Exhibits
Items (2)

Item 7.01. Regulation FD Disclosure. Furnished herewith as Exhibit 99.1 is AIM’s January 2026 Corporate Presentation. The information, including Exhibit 99.1 referenced herein, is “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, if and to the extent such subsequent filing specifically references the information herein as being incorporated by reference in such filing. Cautionary Statement Regarding Forward-Looking Statements

Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibits are filed herewith: